Tilray: 250 Million Reasons Shareholders Aren't Happy
Read the full article on Seeking Alpha.
Disclosure: No position mentioned. Please review th disclaimer page for more details.
Update - Sept. 10
Tilray still got approval to triple the business via acquisitions which is a rather odd goal. Any company can buy revenues, good companies grow it organically.
-Tilray (TLRY -0.9%) announced that majority holding stockholders approved an increase in the number of authorized shares of its common stock.
-Since the merger which closed in May 2021, the new Tilray has made substantial strides across its business, by driving increased revenue through rapidly expanding its international medical business, introducing a new medical brand in Canada while increasing its share in that market, and making strong progress towards its target of $80M in synergies.
-With additional authorized shares, Tilray is now able to accelerate its progress towards its goal of delivering $4B in revenue by FY24 end.